Responses
Emerging Technologies, Pharmacology and Therapeutics
Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
Compose a Response to This Article
Other responses
No responses have been published for this article.